Implications of the Landmark ISCHEMIA Trial on the Initial Management of High-Risk Patients with Stable Ischemic Heart Disease

被引：0
|
作者：
Paniz Vafaei
Sahar Naderi
Andrew P. Ambrosy
Justin J. Slade
机构：
[1] Kaiser Permanente San Francisco Medical Center,Department of Cardiology
[2] Kaiser Permanente Northern California,Division of Research
来源：
Current Atherosclerosis Reports | 2021年 / 23卷
关键词：
Stable ischemic heart disease; Coronary artery disease; Optimal medical therapy; Percutaneous coronary intervention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Implications of the Landmark ISCHEMIA Trial on the Initial Management of High-Risk Patients with Stable Ischemic Heart Disease
    Vafaei, Paniz
    Naderi, Sahar
    Ambrosy, Andrew P.
    Slade, Justin J.
    CURRENT ATHEROSCLEROSIS REPORTS, 2021, 23 (11)
  • [2] Beyond the ISCHEMIA Trial: Revascularization for Stable Ischemic Heart Disease in Patients With High-Risk Coronary Anatomical Features
    Bergmark, Brian A.
    Morrow, David A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (01): : 1 - 4
  • [3] Lessons Learned from the ISCHEMIA Trial for the Management of Patients with Stable Ischemic Heart Disease
    Boden, William E.
    Stone, Peter H.
    ANNUAL REVIEW OF MEDICINE, 2023, 74 : 189 - 198
  • [4] High-Risk Percutaneous Coronary Intervention in Patients With Stable Ischemic Heart Disease
    Weintraub, William S.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2019, 20 (04) : 269 - 270
  • [5] Metabolic approach in the management of ischemic heart disease in high-risk patients - Introduction
    Stanley, William C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (5A): : 1J - 2J
  • [6] A chronotherapeutic approach to the management of high-risk patients with hypertension ischemic heart disease - Introduction
    Black, HR
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (02) : 33S - 34S
  • [7] Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction Insights From the ISCHEMIA Trial
    Lopes, Renato D.
    Alexander, Karen P.
    Stevens, Susanna R.
    Reynolds, Harmony R.
    Stone, Gregg W.
    Pina, Ileana L.
    Rockhold, Frank W.
    Elghamaz, Ahmed
    Lopez-Sendon, Jose Luis
    Farsky, Pedro S.
    Chernyavskiy, Alexander M.
    Diaz, Ariel
    Phaneuf, Denis
    De Belder, Mark A.
    Ma, Yi-tong
    Guzman, Luis A.
    Khouri, Michel
    Sionis, Alessandro
    Hausenloy, Derek J.
    Doerr, Rolf
    Selvanayagam, Joseph B.
    Maggioni, Aldo Pietro
    Hochman, Judith S.
    Maron, David J.
    CIRCULATION, 2020, 142 (18) : 1725 - 1735
  • [8] The clinical significance of procedural myocardial infarction in stable ischemic heart disease patients and implications for interpretation of Ischemia trial a registry analysis
    Das, S.
    Tran, Q.
    Moosavi, V.
    Itty, C.
    Farshid, A.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1235 - 1235
  • [9] Contemporary Management of Patients with Stable Ischemic Heart Disease
    Lyubarova, Radmila
    Schulman-Marcus, Joshua
    Boden, William E.
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2019, 3 (03) : 269 - 278
  • [10] The role of ISCHEMIA in stable ischemic heart disease
    Spilias, Nikolaos
    Zorach, Benjamin
    Denby, Kara
    Ellis, Stephen
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2020, 87 (07) : 401 - 409
12345